Avadel Pharma (AVDL) Earnings
|
Expand Research on AVDL
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +7.0% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/9/26 |
Q425 | N/A | $0.10 | N/A | N/A | $78.68M | = | N/A | N/A | ||
| 11/4/25 |
Q325 | $0.00 | $0.07 | -$0.07 | $77.4M | $73.58M | = | ![]() | ![]() | Details | |
| 8/7/25 | Q225 | $0.10 | $0.03 | +$0.07 | $68.13M | $61.4M | = | ![]() | ![]() | Details | |
| 5/7/25 | Q125 | -$0.05 | -$0.06 | +$0.01 | $52.5M | $53.25M | = | ![]() | ![]() | Details | |
| 3/3/25 | Q424 | -$0.05 | -$0.02 | -$0.03 | $50.41M | $52.48M | = | ![]() | ![]() | Details | |
| 11/12/24 | Q324 | -$0.03 | -$0.08 | +$0.05 | $50.03M | $48.44M | N/A | ![]() | ![]() | Details | |
| 8/8/24 | Q224 | -$0.14 | -$0.18 | +$0.04 | $41.5M | $37.47M | N/A | ![]() | ![]() | Details | |
| 5/8/24 | Q124 | -$0.30 | -$0.23 | -$0.07 | $27.18M | $26.17M | N/A | ![]() | ![]() | Details |


